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CVLTAbstract Background: The pathophysiology and diagnosis of Neuropsychiatric Systemic lupus
erythematosus (NPSLE) are diverse and complicated. Cognitive dysfunction has an important
impact on patients’ quality of life.
Aim of the work: To compare the memory process and components between SLE patients and
the normal subjects.
Patients and methods: This cross-sectional case control study included 40 SLE patients and 40
age and sex matched controls. Patients were recruited from Hafez Hospital Lupus clinic, Shiraz,
Iran. Early dementia, psychosis and other major psychiatric disorders were ruled out. The patients’
memory was evaluated by California Verbal Learning Test (CVLT) and verbal and visual paired of
Wechsler Memory test-Revised (WMS-R).
Results: The age of the patients was 33.3 ± 9.7 years. Memory components (visual and verbal
memory) (p= 0.001 and p= 0.05) and memory processes were signiﬁcantly impaired in SLE
patients compared to the control (Immediate memory p= 0.001, short delay free recall
p= 0.003, cued recall p= 0.001, long delay free recall p= 0.001, cued recall p= 0.02 and recog-
nition correct p= 0.012). Patients with SLE showed poor memory function but the learning slope
in the two groups was comparable (p= 0.45). The CVLT evaluated classiﬁcation of memory pro-
cesses (70.5%) better than memory component (67.5%).
Conclusion: Although patients with SLE had normal learning slope, their function in memory,
components and processes were impaired compared to the normal ones. These ﬁndings suggest that
S14 A. Mani et al.cognitive rehabilitation is considered as a supportive therapy for the neuropsychiatric deﬁcits in
SLE patients to have a better quality of life and to stop the inﬂuence of memory impairment on
daily activities.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Rheumatic
Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Systemic lupus erythematosus (SLE) is a chronic, autoim-
mune, multiorganic disease with a broad spectrum of clinical
manifestations [1,2]. Neuropsychiatric Systemic lupus erythe-
matosus (NPSLE) contributes to the prognosis of SLE. The
pathophysiology and diagnosis of NPSLE are diverse and
complicated. Autoantibodies, complement components and
cytokines are implicated in its pathogenesis [3]. The assessment
of neuropsychiatric involvement in SLE patients is challenging
and the available diagnostic tools fail to guarantee optimal
diagnostic accuracy, sensitivity to changes as well as feasibility
in routine clinical care [4]. Neuropsychiatric lupus was esti-
mated to range from 26% to 81% [5–10]. Prevalence of clinical
manifestation in Iran according to the survey on 2143 SLE
cases shows that prevalence of neuropsychiatric manifestations
was about 24% [10]. These manifestations are common among
SLE patients albeit presented in diverse central nervous system
syndromes such as aseptic meningitis, cerebrovascular disor-
ders, demyelinization syndrome, headache, states of confusion,
anxiety disorders, mood disorders, cognitive impairment, and
psychosis [1,12].
Cognitive dysfunction is a psychiatric manifestation
included in the description of NPSLE. It is among the most
prevalent in SLE having an important impact on patients’
quality of life. However, the unknown etiology allied to the
lack of clarity on the best diagnosis procedure, makes early
diagnosis difﬁcult [13]. Most studies refer to overt psychiatric
symptoms that were clinically obvious; small changes like mild
cognitive impairment (MCI) are often left unnoticed [14]. It
has been reported that cognitive dysfunction is a prominent
feature also in SLE patients without symptoms of CNS
involvement [15]. Cognitive dysfunction has been reported to
be present in 20–60% of SLE patients [16]. Clinical cognitive
dysfunction has also been recently reported in 11.4% of SLE
patients, however, MRI brain in these patients showed abnor-
malities in 59.3% [17]. Thus if the MCI are included, the
prevalence of psychiatric abnormalities present in SLE would
reach 90% [18].
Mild cognitive impairment patients complain of cognitive
decline especially memory impairments which interfered with
their daily activity; even in the absence of overt neuropsychi-
atric symptoms; cognitive dysfunction has been frequently
reported. Accordingly, SLE patients often complain of cogni-
tive difﬁculties that are not speciﬁc to one brain region or cog-
nitive domain, and in the majority of patients they are
subclinical and mainly ignored in medical evaluation [5,19].
Different studies reveal that SLE patients show impairment
in their cognitive function but these deﬁcits are not congruent
[5,14,19,20]. Memory appears to be one of the most consis-
tently affected parts [21]; its impairment is related to hip-
pocampal changes [19]. Memory is one of the most
important cognitive functions in different daily activities andits disturbance is vital. It is common in neuropsychological set-
tings to evaluate memory processes and memory component
among those who have subjective memory complaints.
Accordingly, the main purpose of the present study is to
compare memory and learning between SLE and healthy con-
trol individuals. In the present study, we investigated whether
memory and learning can discriminate between SLE and con-
trol subjects; it could be helpful considering cognitive deﬁcit in
these patients.2. Patients and methods
This is a cross-sectional case-controlled study conducted
through convenience sampling from Lupus clinic afﬁliated to
Shiraz University of Medical Sciences, Shiraz, Southern Iran.
The patients (n= 40) were selected according to the following
inclusion criteria: patients with lupus who fulﬁlled the criteria
of American College of Rheumatology Revised Classiﬁcation
Criteria for SLE [22], age between 18 and 60, education more
than primary. Besides, patients with current pregnancy, uncor-
rected vision problems that would interfere with reading abil-
ity, poor medical condition that disturbs patient’s mental
status like fever, renal failure needing hemodialysis, post-
seizure status, previous brain infarction detected in clinic and
approved by Brain CT scan or Brain MRI, and patients with
overlap syndromes were excluded. The patients using med-
ications with effects on mental status were also excluded.
The present study was approved by the Ethics Committee of
the Shiraz University of Medical Sciences before it was imple-
mented. Written informed consent was obtained from all sub-
jects to participate in the study, and they were free to withdraw
at any time, and were ensured of the conﬁdentiality of the data.
Forty age and sex matched apparently healthy subjected were
included as a control group.
The patients and control completed the following task in
one session (i) Mini Mental Status Examination (MMSE),
used to screen the subjects for ruling out early dementia [23];
(ii) Psychiatric Interview based on DSM IV-TR which is used
to rule out psychosis and other major psychiatric disorders;
(iii) California Verbal Learning Test (CVLT) which is used
to determine the subjects’ process of memory, such as immedi-
ate memory, short and long free recall, short and long cue
recall, recognition and learning slope [24]; and (iv) Verbal
and Visual paired associates of Wechsler Memory test-
Revised, used to determine the subjects’ verbal and visual
memory [25].
Statistical analysis: SPSS software, version 16, was applied
for statistical analysis. Statistical analysis of seven subscales of
CVLT was performed by Student’s t-test, two tailed and dis-
crimination analysis to evaluate how accurate memory and
learning can discriminate between SLE and healthy control
group. A p value less than 0.05 was considered signiﬁcant.
Table 1 Demographic and cognitive characteristics of SLE and normal subjects.
Variables mean ± SD SLE Control CI 95% p
Age 33.3 ± 9.7 36.4 ± 5.6 6.8–0.6 0.1
MMSE 27.1 ± 4.1 26.6 ± 0.96 3.9–1.1 0.001
Memory components (paired associated)
Verbal 18.2 ± 3.6 21 ± 3 4.3–1.4 0.001
Visual 10.8 ± 3.8 12.7 ± 4.9 3.9–0.001 0.05
Memory processes
Immediate memory 52.6 ± 7.97 59.5 ± 10.1 11.02–2.8 0.001
Short delay
Free recall 11.4 ± 3.3 13.4 ± 2.5 3.3–0.7 0.003
Cued recall 12.2 ± 2.3 14.1 ± 2.5 2.9–0.8 0.001
Long delay
Free recall 10.8 ± 3.3 13.3 ± 2.4 3.7–1.2 0.001
Cued recall 12.1 ± 2.9 13.6 ± 2.8 2.8–0.2 0.02
Recognition correct 14.4 ± 2.4 15.6 ± 0.8 2.2–0.3 0.012
Learning slope 1.6 ± 0.6 1.7 ± 0.5 0.3–0.2 0.45
MMSE: Mini Mental Statues Examination.
Table 2 Classiﬁcation analysis for memory component and
memory processes.
Memory N (%) Groups Predicted membership Total
SLE Normal
Componentsa SLE 26 (65) 14 (35) 40 (100)
Normal 12 (30) 28 (70) 40 (100)
Processesb SLE 24 (60) 14 (40) 40 (100)
Normal 9 (22.5) 31 (77.5) 40 (100)
a 67.5% of original grouped cases correctly classiﬁed.
b 70.5% of original grouped cases correctly classiﬁed.
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Various demographic and cognitive variables were analyzed.
Cognition variables were signiﬁcantly impaired in the SLE
patients compared to the control (Table 1). There were no
signiﬁcant differences between both groups based on learning
slope, but other memory components and processes were
signiﬁcant. It should be mentioned that, though there were
signiﬁcant differences between groups on MMSE, both group
means were in the normal range, so none of the subjects had
clinical cognitive impairment.
Regarding the memory component (verbal and visual mem-
ory) or memory processes (short/delay recall), results indicated
that CVLT which evaluated memory processes better classiﬁed
the groups (about 70.5%) than memory component. The mem-
ory component classiﬁed the groups about 67.5% (Table 2).
The SLE patients could not recognize the words which were
presented ﬁve times according to the CVLT manual.
4. Discussion
Patients with SLE can be affected by a multitude of neurologic
and psychiatric symptoms with a wide range of prevalence and
severity. Irrespectively from attribution to SLE or othercauses, neuropsychiatric symptoms strongly impact short and
long-term outcomes and thus its evaluation during routine
clinical practice in SLE should be undertaken regularly [4].
The main purpose of the present study was to evaluate one
of the controversial domains of neuropsychological impair-
ment between patients with SLE and normal control group.
According to a previous study [26], memory is impaired in
these patients in different ways. The researchers had different
convincing reasons for these deﬁcits, but their conclusion is
limited to their culture and language, so it seems that it is
necessary to evaluate cognitive function in the Persian lan-
guage (formal language of Iran). Accordingly, 40 SLE patients
and 40 normal persons participated in the study. These partici-
pants were in the normal range of cognitive functions accord-
ing to MMSE score (means up to 26). The main ﬁnding of this
study was that six subscales of CVLT and visual and verbal
paired did show a signiﬁcant evidence of memory reproduction
deﬁcits in SLE patients as compared to normal ones, though
their MMSE was normal. Learning slope in both groups was
in the normal range; it means that both groups acquired the
words sufﬁciently via repetition of list A of CVLT. Learning
slope was comparable between the patients with SLE and nor-
mal ones. So it was obvious that learning slope would be con-
structed in these patients, but they could not have memory
processes.
In addition to other medical problems due to SLE such as
musculoskeletal, cutaneous, renal, pulmonary, cardiac and
hematologic [11], in the present study it was concluded that
the patients showed some impairments in cognitive processes.
The results were in line with Emori et al. and Glanz et al.
[26,27] studies, showing memory impairments in memory com-
ponents such as visual and verbal and memory processes such
as immediate, cued and free recall and recognition. Emori et al.
indicated that this pattern of memory deﬁcit had no relation-
ship with the presence or absence of antiphospholipid antibody
and it might be neuropsychological symptoms which are seen
in SLE patients [26]. Also, in their study, patients with SLE
had a normal value of verbal recognition as seen in the Rey
verbal recognition task, while they had lower values of verbal
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delayed and interference) and the paired associates. These ﬁnd-
ings were not in line with our results. In our study, the SLE
patients could not recognize the words which were presented
ﬁve times according to CVLT manual; it can be concluded that
these patients might have poorer attention process as con-
ﬁrmed by WHO, reporting that problem in attention processes
is common among SLE patients [28].
In line with Coin-Mejias et al. [1], the present study shows
that SLE patients have impaired visual memory too. Although
it has been revealed that visuospatial processing (visual mem-
ory) remains intact in SLE patients [28], it might be related to
the right temporal lobe deﬁcit which was mentioned in Coin-
Mejias et al.’s study [1]. Besides, it could be concluded that
decreased verbal memory reﬂects dysfunction in the strategy
when verbal information was taken or recollected in the mem-
ory process of SLE patients. On the other hand, Watson et al.
[29] suggested that impaired memory in SLE patients might be
due to hippocampal dysfunction.
In a recent study, reduced psychomotor speed is reported to
be an SLE-speciﬁc pattern of Neurocognitive impairment
(NCI). Verbal-memory deﬁcits were not evident among SLE
patients who were corticosteroid-naive. Impaired psychomotor
speed may be added to the symptoms of early SLE [30]. It is
recommended in future studies that the disease activity and
damage as well as the medications received by the SLE patients
are taken into consideration in relation to the cognitive
function.
In conclusion, interestingly, the present research found that
patients with SLE compared to the normal control group had
no signiﬁcant differences in learning and could have compara-
ble learning slope like the normal group. This ﬁnding reveals
that cognitive rehabilitation should be accepted as a supportive
therapy for their neuropsychiatric deﬁcit to have a better qual-
ity of life and stop the inﬂuence of memory impairment on
daily activity.
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